AN OVERVIEW OF PARKINSON'S DISEASE TREATMENT AND IT'S STRATEGIES

Parkinson's disease (PD) is a neurological condition that typically manifests between the age of 55 and 65. The entire quality of life is significantly impacted by the increasing development of both motor and non-motor symptoms. Although there isn't a cure, a number of therapies have been created to assist control Parkinson's disease symptoms. The discipline of Parkinson's disease (PD) management is expanding and focuses on both novel and improved therapeutic approaches. Physicians can now address patient-specific issues as they emerge in addition to the primary motor symptoms of Parkinson's disease (PD) thanks to pharmaceutical, surgical and therapy interventions. But the therapeutic approach to this condition should incorporate both pharmacological and non-pharmacological strategies. Therefore, in order to improve these treatments and consequently, the patient’s quality of life, further research into the biology of the condition is required. The established and novel options for treating Parkinson's disease (PD) that can offer patient-specific care and lessen the negative effects of standard therapies are covered in this review.

Authors

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-05-01
DOI
https://doi.org/10.5281/zenodo.19874916
Primary Topic
Parkinson's Disease Mechanisms and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

AN OVERVIEW OF PARKINSON'S DISEASE TREATMENT AND IT'S STRATEGIES

Soujanya Munegowda1*, Alfiya2, Priyanka Anjinappa3
Zenodo (CERN European Organization for Nuclear Research)
Parkinson's Disease Mechanisms and Treatments
article

AN OVERVIEW OF PARKINSON'S DISEASE TREATMENT AND IT'S STRATEGIES

Soujanya Munegowda1*, Alfiya2, Priyanka Anjinappa3
article en

Abstract

Parkinson's disease (PD) is a neurological condition that typically manifests between the age of 55 and 65. The entire quality of life is significantly impacted by the increasing development of both motor and non-motor symptoms. Although there isn't a cure, a number of therapies have been created to assist control Parkinson's disease symptoms. The discipline of Parkinson's disease (PD) management is expanding and focuses on both novel and improved therapeutic approaches. Physicians can now address patient-specific issues as they emerge in addition to the primary motor symptoms of Parkinson's disease (PD) thanks to pharmaceutical, surgical and therapy interventions. But the therapeutic approach to this condition should incorporate both pharmacological and non-pharmacological strategies. Therefore, in order to improve these treatments and consequently, the patient’s quality of life, further research into the biology of the condition is required. The established and novel options for treating Parkinson's disease (PD) that can offer patient-specific care and lessen the negative effects of standard therapies are covered in this review.

Zenodo (CERN European Organization for Nuclear Research)
Openalex Percentile: Top 5%
Parkinson's Disease Mechanisms and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

AN OVERVIEW OF PARKINSON'S DISEASE TREATMENT AND IT'S STRATEGIES — Soujanya Munegowda1*, Alfiya2, Priyanka Anjinappa3 · Zenodo (CERN European Organization for Nuclear Research) (2026) | TGRS Research Map | TGRS